Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Notes Payables (2016 - 2020)

Altimmune (ALT) has disclosed Notes Payables for 7 consecutive years, with $632000.0 as the latest value for Q2 2020.

  • Quarterly Notes Payables rose 286.02% to $632000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $632000.0 through Jun 2020, up 286.02% year-over-year, with the annual reading at $71596.0 for FY2018, 44.05% up from the prior year.
  • Notes Payables for Q2 2020 was $632000.0 at Altimmune, up from $105062.0 in the prior quarter.
  • The five-year high for Notes Payables was $1.5 million in Q3 2018, with the low at $49702.0 in Q2 2017.
  • Average Notes Payables over 5 years is $386259.6, with a median of $134393.0 recorded in 2019.
  • The sharpest move saw Notes Payables skyrocketed 2852.11% in 2018, then plummeted 92.84% in 2019.
  • Over 5 years, Notes Payables stood at $458629.0 in 2016, then crashed by 89.16% to $49702.0 in 2017, then soared by 44.05% to $71596.0 in 2018, then soared by 46.74% to $105062.0 in 2019, then soared by 501.55% to $632000.0 in 2020.
  • According to Business Quant data, Notes Payables over the past three periods came in at $632000.0, $105062.0, and $163724.0 for Q2 2020, Q3 2019, and Q2 2019 respectively.